Back to top
more

Abbott Laboratories (ABT)

(Delayed Data from NYSE)

$110.94 USD

110.94
7,458,602

+1.05 (0.96%)

Updated Aug 15, 2024 04:00 PM ET

After-Market: $110.95 +0.01 (0.01%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.03%
2Buy17.70%
3Hold9.37%
4Sell5.03%
5Strong Sell2.48%
S&P50011.19%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value D Growth B Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 39% (99 out of 251)

Industry: Medical - Products

Better trading starts here.

Zacks News

Infosys (INFY) to Report Q1 Earnings: What's in the Offing?

While Infosys' (INFY) Q1 performance is likely to have benefited from the ongoing digital transformations and large deal wins, elevated expenses might have hurt the bottom line.

Sheraz Mian headshot

Top Analyst Reports for Oracle, Abbott & Chevron

Today's Research Daily features new research reports on 16 major stocks, including Oracle (ORCL), Abbott Laboratories (ABT) and Chevron (CVX).

Analysts Estimate Abbott (ABT) to Report a Decline in Earnings: What to Look Out for

Abbott (ABT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Is Abbott Laboratories (ABT) Outperforming Other Medical Stocks This Year?

Is (ABT) Outperforming Other Medical Stocks This Year?

Bio-Rad (BIO) Banks on Coronavirus PCR Tests Amid Cost Woes

Bio-Rad (BIO) rides on the FDA's emergency use authorization EUA for the Droplet Digital PCR COVID-19 test kit.

LabCorp Launches At-Home Coronavirus Test Collection Kit

LabCorp (LH) claims this to be the first digital COVID-19 service that physicians can use to remotely diagnose patients before any surgery or procedure.

Danaher Shares Gain 26% in 3 Months: What's Driving the Rally?

Danaher (DHR), with 26% growth in shares in the past three months, benefits from healthy demand for its products and synergistic benefits from acquired assets despite the pandemic-led woes.

The Zacks Analyst Blog Highlights: Abbott Laboratories, Zoom Video Communications, Amazon.com and NVIDIA

The Zacks Analyst Blog Highlights: Abbott Laboratories, Zoom Video Communications, Amazon.com and NVIDIA

Tirthankar Chakraborty headshot

4 Stocks to Play the Alarming Spike in Cases of COVID-19

From an investment perspective, the spurt in new coronavirus cases over the July fourth weekend bodes well for certain stocks.

Trina Mukherjee headshot

Medical Products Industry's Near-Term Outlook Lacks Spark

AI & Robotics can drive the medical products industry amid the coronavirus-induced crisis.

Abbott (ABT) Outpaces Stock Market Gains: What You Should Know

Abbott (ABT) closed the most recent trading day at $92.23, moving +0.64% from the previous trading session.

Trina Mukherjee headshot

3 MedTech Stocks to Buy Amid Intensifying Coronavirus Fears

Let's keep a watch on three stocks that have shown tremendous promise amid the pandemic.

Abbott, Tandem Diabetes Seal Deal on Diabetes Management

Abbott's (ABT) FreeStyle Libre CGM technology to be integrated with Tandem Diabetes' insulin pumps to enhance diabetes care.

Abbott (ABT) Stock Moves -1.02%: What You Should Know

Abbott (ABT) closed the most recent trading day at $88.71, moving -1.02% from the previous trading session.

Debanjana Dey headshot

Coronavirus Diagnostic Tests in High Demand: 4 Stocks in Focus

Amid the pandemic, these four companies with strong diagnostics testing developments might show better resilience.

Abbott (ABT) Stock Sinks As Market Gains: What You Should Know

Abbott (ABT) closed at $90.28 in the latest trading session, marking a -0.68% move from the prior day.

Trina Mukherjee headshot

3 MedTech Stocks to Watch Amid Coronavirus Catastrophe

Let's keep a watch on three stocks that have displayed strong performance amid market turmoil led by the ongoing pandemic.

Abbott's Libre 2 iCGM Gets FDA Nod to Better Manage Diabetes

Abbott's (ABT) FDA-cleared FreeStyle Libre 2 iCGM is the only available system to continuously transmit glucose data with real-time alarms.

Abbott's (ABT) FreeStyle Libre Study Outcome Favorable

The latest study outcome aligns with the American Diabetes Association's recommended A1c level of 7% for adults with diabetes.

Abbott (ABT) Outpaces Stock Market Gains: What You Should Know

In the latest trading session, Abbott (ABT) closed at $89.02, marking a +1.41% move from the previous day.

Sriparna Ghosal headshot

3 Diabetes Management Stocks in the Spotlight Amid Coronavirus

Amid the widespread pandemic crisis, the diabetes management sector continues to thrive on account of multiple positive developments

Trina Mukherjee headshot

Diagnostic Testing Remains Crucial in Combatting Coronavirus

Let's keep a watch on three stocks that are focused on offering advanced diagnostic testing to fight against coronavirus.

Danaher's (DHR) Product Offerings to Aid Amid Pandemic Scares

Danaher's (DHR) risks from pandemic-related uncertainties are evident from weak sales projections for the second quarter. Demand for acute care diagnostics' related products might aid results.

Abbott Stock Down on Urgent Field Safety Notice for TactiCath

Abbott (ABT) also mentions certain guidelines related to product return, reporting, and customer assistance.

Abbott (ABT) Stock Sinks As Market Gains: What You Should Know

Abbott (ABT) closed at $92.62 in the latest trading session, marking a -0.42% move from the prior day.